Literature DB >> 14726450

A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity.

Carola W E Meyer1, Dirk Korthaus, Wolfgang Jagla, Emmanuelle Cornali, Johannes Grosse, Helmut Fuchs, Martin Klingenspor, Stephanie Roemheld, Matthias Tschöp, Gerhard Heldmaier, Martin Hrabé De Angelis, Michael Nehls.   

Abstract

The SMA1-mouse is a novel ethyl-nitroso-urea (ENU)-induced mouse mutant that carries an a-->g missense mutation in exon 5 of the GH gene, which translates to a D167G amino acid exchange in the mature protein. Mice carrying the mutation are characterized by dwarfism, predominantly due to the reduction (sma1/+) or absence (sma1/sma1) of the GH-mediated peripubertal growth spurt, with sma1/+ mice displaying a less pronounced phenotype. All genotypes are viable and fertile, and the mode of inheritance is in accordance with a semidominant Mendelian trait. Adult SMA1 mice accumulate excessive amounts of sc and visceral fat in the presence of elevated plasma ghrelin levels, possibly reflecting altered energy partitioning. Our results suggest impaired storage and/or secretion of pituitary GH in mutants, resulting in reduced pituitary GH and reduced GH-stimulated IGF-1 expression. Generation and identification of the SMA1 mouse exemplifies the power of the combination of random mouse mutagenesis with a highly detailed phenotype-analysis as a successful strategy for the detection and analysis of novel gene-function relationships.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726450     DOI: 10.1210/en.2003-1125

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Two-year body composition analyses of long-lived GHR null mice.

Authors:  Darlene E Berryman; Edward O List; Amanda J Palmer; Min-Yu Chung; Jacob Wright-Piekarski; Ellen Lubbers; Patrick O'Connor; Shigeru Okada; John J Kopchick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-11-09       Impact factor: 6.053

2.  The negative association between plasma ghrelin and IGF-I is modified by obesity, insulin resistance and type 2 diabetes.

Authors:  S M Pöykkö; O Ukkola; H Kauma; E Kellokoski; S Hörkkö; Y A Kesäniemi
Journal:  Diabetologia       Date:  2005-02-02       Impact factor: 10.122

Review 3.  Growth hormone and adipose tissue: beyond the adipocyte.

Authors:  Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2011-04-05       Impact factor: 2.372

Review 4.  Mouse behavioural analysis in systems biology.

Authors:  Peter Van Meer; Jacob Raber
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

5.  Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini.

Authors:  Sarah K McMenamin; James E N Minchin; Tiffany N Gordon; John F Rawls; David M Parichy
Journal:  Endocrinology       Date:  2013-03-01       Impact factor: 4.736

6.  Imprint switch mutations at Rasgrf1 support conflict hypothesis of imprinting and define a growth control mechanism upstream of IGF1.

Authors:  Nadia M Drake; Yoon Jung Park; Aditya S Shirali; Thomas A Cleland; Paul D Soloway
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

7.  The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice.

Authors:  Xue Gao; Yong-Hyun Shin; Min Li; Fei Wang; Qiang Tong; Pumin Zhang
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

8.  Neural growth hormone implicated in body weight sex differences.

Authors:  Paul J Bonthuis; Emilie F Rissman
Journal:  Endocrinology       Date:  2013-07-16       Impact factor: 4.736

9.  Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

Authors:  Richard W Gelling; Wenbo Yan; Salwa Al-Noori; Aaron Pardini; Gregory J Morton; Kayoko Ogimoto; Michael W Schwartz; Peter J Dempsey
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

10.  A dwarf mouse model with decreased GH/IGF-1 activity that does not experience life-span extension: potential impact of increased adiposity, leptin, and insulin with advancing age.

Authors:  Darlene E Berryman; Ellen R Lubbers; Vishakha Magon; Edward O List; John J Kopchick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-05-21       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.